|
Sangon Biotech
25-bp complementary dna oligonucleotides with a 20-bp target sequence 25 Bp Complementary Dna Oligonucleotides With A 20 Bp Target Sequence, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/25-bp complementary dna oligonucleotides with a 20-bp target sequence/product/Sangon Biotech Average 90 stars, based on 1 article reviews
25-bp complementary dna oligonucleotides with a 20-bp target sequence - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Clinical and Laboratory Standards Institute
interpretive criteria for identification of bacteria and fungi by dna target sequencing Interpretive Criteria For Identification Of Bacteria And Fungi By Dna Target Sequencing, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/interpretive criteria for identification of bacteria and fungi by dna target sequencing/product/Clinical and Laboratory Standards Institute Average 90 stars, based on 1 article reviews
interpretive criteria for identification of bacteria and fungi by dna target sequencing - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Bioscientifica Ltd
guide rna (grna) dna target sequence Guide Rna (Grna) Dna Target Sequence, supplied by Bioscientifica Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/guide rna (grna) dna target sequence/product/Bioscientifica Ltd Average 90 stars, based on 1 article reviews
guide rna (grna) dna target sequence - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Bioneer Corporation
target dna sequence: 5′-ggg gat ccc gat ctc ag-3′ Target Dna Sequence: 5′ Ggg Gat Ccc Gat Ctc Ag 3′, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/target dna sequence: 5′-ggg gat ccc gat ctc ag-3′/product/Bioneer Corporation Average 90 stars, based on 1 article reviews
target dna sequence: 5′-ggg gat ccc gat ctc ag-3′ - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
custom dna target enrichment panel nextseq 500 nextgeneration sequencing Custom Dna Target Enrichment Panel Nextseq 500 Nextgeneration Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/custom dna target enrichment panel nextseq 500 nextgeneration sequencing/product/Illumina Inc Average 90 stars, based on 1 article reviews
custom dna target enrichment panel nextseq 500 nextgeneration sequencing - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Oncologica Uk
targeted dna sequencing Targeted Dna Sequencing, supplied by Oncologica Uk, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/targeted dna sequencing/product/Oncologica Uk Average 90 stars, based on 1 article reviews
targeted dna sequencing - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Eurofins
mismatched target dna sequences 2, 10, 20 ![]() Mismatched Target Dna Sequences 2, 10, 20, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mismatched target dna sequences 2, 10, 20/product/Eurofins Average 90 stars, based on 1 article reviews
mismatched target dna sequences 2, 10, 20 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Amoy Diagnostics
targeted 559 gene dna sequencing amoydx® master panel ![]() Targeted 559 Gene Dna Sequencing Amoydx® Master Panel, supplied by Amoy Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/targeted 559 gene dna sequencing amoydx® master panel/product/Amoy Diagnostics Average 90 stars, based on 1 article reviews
targeted 559 gene dna sequencing amoydx® master panel - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
targeted dna sequencing of prostate tumours ![]() Targeted Dna Sequencing Of Prostate Tumours, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/targeted dna sequencing of prostate tumours/product/Illumina Inc Average 90 stars, based on 1 article reviews
targeted dna sequencing of prostate tumours - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Mission Bio
microfluidics-based, high-throughput targeted dna single cell sequencing platform ![]() Microfluidics Based, High Throughput Targeted Dna Single Cell Sequencing Platform, supplied by Mission Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/microfluidics-based, high-throughput targeted dna single cell sequencing platform/product/Mission Bio Average 90 stars, based on 1 article reviews
microfluidics-based, high-throughput targeted dna single cell sequencing platform - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Microsynth ag
cx3cl1 probe rv (including t7 promoter) ![]() Cx3cl1 Probe Rv (Including T7 Promoter), supplied by Microsynth ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cx3cl1 probe rv (including t7 promoter)/product/Microsynth ag Average 90 stars, based on 1 article reviews
cx3cl1 probe rv (including t7 promoter) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
targeted dna sequencing illumina myeloid panel ![]() Targeted Dna Sequencing Illumina Myeloid Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/targeted dna sequencing illumina myeloid panel/product/Illumina Inc Average 90 stars, based on 1 article reviews
targeted dna sequencing illumina myeloid panel - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain
doi: 10.1101/2022.03.15.484427
Figure Lengend Snippet: Structural organization of Francisella novicida Cas12a (FnCas12a) and influence of helix 1 mutations on the overall structure and thermo stability. ( A ) Domain organization of FnCas12a with mutation sites indicated in red. ( B ) Structure of the binary complex of FnCas12a with crRNA (orange) (PDB: 5NG6). ( C ) Structure of the ternary complex of FnCas12a together with crRNA (orange) and target DNA (black) (PDB: 6I1K). ( B ) and ( C ) Protein domains are colored according to the domain organization in (A). Helix 1, a part of RuvC II domain, is colored in dark blue, the bridge helix (BH) in green. ( D ) and ( E ) Close-up of helix 1 (blue) and BH (green) in the binary (D) and ternary (E) state, showing the change of helical lengths upon the rearrangement from binary to ternary complex. Mutation sites I960, K978, and K981 are shown in red. ( F ) Far-UV CD spectra of WT FnCas12a and FnCas12a helix 1 variants (2 µM) at 25 °C. Shown is the average of five replicates. ( G ) Protein Thermal Shift™ (Thermo Scientific) melting curves of FnCas12a variants (2 µg) from 25 to 95 °C. Shown is the average of four replicates.
Article Snippet: The matched target MM 0 as well as the mismatched
Techniques: Mutagenesis
Journal: bioRxiv
Article Title: Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain
doi: 10.1101/2022.03.15.484427
Figure Lengend Snippet: Single molecule Förster resonance energy transfer (FRET) measurements of freely diffusing molecules were conducted of doubly labeled FnCas12a REC-Nuc*DL550/DL650 helix 1 variants in comparison to WT FnCas12a REC-Nuc*DL550/DL650 . ( A ) Schematic illustration of FnCas12a with labeling positions in the Nuc domain (T1222) and the REC domain (D470). ( B ) FRET efficiency histograms of FnCas12a I960P/K981P REC-Nuc*DL550/DL650 , FnCas12a Δh1 REC-Nuc*DL550/DL650 , and FnCas12a ΔBH/Δh1REC-Nuc*DL550/DL650 compared to WT FnCas12a REC-Nuc*DL550/DL650 of the apo enzyme, the binary complex (1 nM crRNA), the ternary complex (1 nM crRNA, 1 nM target DNA), and the ternary complex without NTS (1 nM crRNA, 1 nM TS DNA). Fitting of the histograms was performed with a double or triple Gaussian function. The averaged mean FRET efficiencies (E) and the percentage distribution of the populations (A) are given with SEs in the histograms. Measurements were performed in triplicates (see also Supplementary Figure S8).
Article Snippet: The matched target MM 0 as well as the mismatched
Techniques: Förster Resonance Energy Transfer, Labeling
Journal: bioRxiv
Article Title: Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain
doi: 10.1101/2022.03.15.484427
Figure Lengend Snippet: Plasmid cleavage assay of FnCas12a h1 variants. The binary complex (37.5 nM FnCas12a + crRNA) was incubated with 5 nM of target DNA at 37 °C for 1 h. ( A ) The linearized target DNA plasmid (7300 bp) is cleaved into two products (4400 and 2900 bp) and analyzed on a 0.8% agarose 1x TAE gel. ( B ) The supercoiled plasmid DNA is nicked or linearized by FnCas12a variants and analyzed on a 1.5% agarose 1x TAE gel. 1 kb plus DNA ladder.
Article Snippet: The matched target MM 0 as well as the mismatched
Techniques: Plasmid Preparation, Cleavage Assay, Incubation
Journal: bioRxiv
Article Title: Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain
doi: 10.1101/2022.03.15.484427
Figure Lengend Snippet: High-resolution cleavage assay of FnCas12a helix 1 variants in comparison to FnCas12a BH variants. The 58 nt double stranded target DNA carries a Cy5 label at the TS and a Cy3 label at the NTS. A 7.5-fold excess of binary complex (Cas12a and crRNA, 750 nM) was used over the target DNA (100 nM). The reaction was incubated for 1 h at 37 °C. ( A ) DNA strands are labeled with Cy3 (green sphere) and Cy5 (red sphere) fluorophores at the 5’-end of the DNA strands, respectively. ( B ) DNA strands are labeled with Cy3 (green sphere) and Cy5 (red sphere) fluorophores at the 3’-end of the DNA strands, respectively. ( C ) Constructs shown in (A) were used. In addition to the previously reported shift of NTS cleavage products of the BH variants the helix 1 deletions variants (Δh1, ΔBH/Δh1) show a shifted cleavage pattern for the TS. ( D ) Constructs shown in (B) were used. The shift in TS cleavage for FnCas12a Δh1 and FnCas12a ΔBH/Δh1 is again observed. FnCas12a I960P/K981P does not show cleavage at all. Samples were analyzed on a denaturing 15% PAA gel.
Article Snippet: The matched target MM 0 as well as the mismatched
Techniques: Cleavage Assay, Incubation, Labeling, Construct
Journal: bioRxiv
Article Title: Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain
doi: 10.1101/2022.03.15.484427
Figure Lengend Snippet: Mechanistic model summarizing the impact of helix 1 on FnCas12a activity. ( A ) Loading of target DNA leads to the formation of the ternary complex. This transition is accompanied by an opening of the enzyme and a tandem movement of helix 1 and the bridge helix (BH), e.g. a shortening of helix 1 (blue cylinder) and extension of the BH (green cylinder). Additionally, the lid domain (cyan) is restructured inducing the formation of a short helix and ultimately the opening and activation of the active site in the RuvC II domain. ( B ) Introduction of proline residues in helix 1 and the BH (kink in the cylinders), respectively, prevents the concerted tandem movement of helix 1 and the BH. The impaired movement of helix 1 is translated to the lid domain that cannot reorder ultimately preventing the opening of the lid. Consequently, the active site is not activated and cis - and trans -DNA cleavage activity cannot be observed.
Article Snippet: The matched target MM 0 as well as the mismatched
Techniques: Activity Assay, Activation Assay